Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Drug Use Surveillance for Cabometyx Tablets "Hepatocellular Carcinoma"

NCT05100082 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT05100082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05100082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Drug Use Surveillance for Cabometyx Tablets "Hepatocellular Carcinoma"
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
November 17, 2021
Completion date
November 30, 2025
Enrollment
263 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular cancer